Sign in
bf/NASDAQ:PSTI_icon.jpeg

NASDAQ:PSTI

Pluristem Therapeutics Inc.

  • Stock

USD

Last Close

1.03

26/07 04:00

Market Cap

40.85M

Beta: 1.91

Volume Today

170.63K

Avg: -

PE Ratio

−0.56

PFCF: −1.31

OverviewFinancialsFilingspeopleOwnershipAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Excel Tearsheet
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
asset turnover
0.01
-
0.01
8.61%
0.06
1,014.41%
0.00
-
0.00
34.39%
0.00
79.65%
cash conversion cycle
-112.80K
-
-89.34K
20.79%
-9.56K
89.30%
-588.95K
-
-406.68K
30.95%
cash per share
8.49
-
7.40
12.75%
4.05
45.32%
2.99
26.25%
2.82
5.43%
1.92
31.94%
2.52
30.90%
2.31
8.18%
company equity multiplier
1.19
-
1.17
1.62%
1.20
2.72%
1.24
3.05%
1.37
10.15%
1.43
4.99%
1.17
18.59%
1.64
40.11%
days of inventory outstanding
days of payables outstanding
114.97K
-
91.76K
20.20%
9.87K
89.24%
595.13K
-
416.28K
30.05%
days of sales outstanding
2.18K
-
2.42K
10.83%
318.08
86.83%
6.18K
-
9.60K
55.34%
25.55K
166.01%
dividend yield
ebit per revenue
-73.48
-
-66.67
9.27%
-8.19
87.71%
-674.62
-
-658
2.46%
-1.28K
94.77%
ebt per ebit
0.97
-
0.98
0.99%
1.00
2.07%
0.99
0.42%
0.77
21.98%
0.99
28.29%
0.99
0.47%
0.99
0.40%
effective tax rate
enterprise value multiple
-7.74
-
-6.83
11.67%
-4.72
30.94%
-4.18
11.41%
-4.99
19.39%
-2.06
58.75%
-5.63
173.42%
-2.16
61.60%
fixed asset turnover
free cash flow per share
-3.26
-
-3.05
6.39%
-2.55
16.44%
-2.52
1.30%
-2.05
18.43%
-2.41
17.35%
-1.46
39.20%
-1.11
23.99%
gross profit margin
0.97
-
0.97
0.54%
0.96
0.09%
0.96
-
0.96
0.31%
1
3.85%
interest coverage
-150.39
-
-649.01
331.56%
inventory turnover
long term debt to capitalization
0.30
-
net income per ebt
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
net profit margin
-71.06
-
-65.11
8.37%
-8.17
87.46%
-522.52
-
-653.83
25.13%
-1.27K
93.85%
operating cash flow per share
-3.01
-
-2.93
2.62%
-2.33
20.58%
-2.47
6.16%
-2.02
18.31%
-2.39
18.27%
-1.45
39.32%
-1.10
24.13%
operating cycle
2.18K
-
2.42K
10.83%
318.08
86.83%
6.18K
-
9.60K
55.34%
operating profit margin
-73.48
-
-66.67
9.27%
-8.19
87.71%
-674.62
-
-658
2.46%
-1.28K
94.77%
payables turnover
0.00
-
0.00
25.31%
0.04
829.33%
0.00
-
0.00
42.96%
pretax profit margin
-71.06
-
-65.11
8.37%
-8.17
87.46%
-522.52
-
-653.83
25.13%
-1.27K
93.85%
price fair value
3.19
-
3.05
4.50%
2.77
8.98%
3.70
33.41%
4.53
22.49%
3.33
26.41%
2.87
14.01%
1.95
32.06%
receivables turnover
0.17
-
0.15
9.77%
1.15
659.36%
0.06
-
0.04
35.63%
0.01
62.41%
return on assets
-0.36
-
-0.36
0.48%
-0.51
39.75%
-0.74
46.45%
-0.67
9.51%
-1.13
68.16%
-0.44
60.55%
-0.53
19.84%
return on capital employed
-0.42
-
-0.41
2.46%
-0.58
42.39%
-0.87
50.25%
-1.11
27.15%
-1.53
38.37%
-0.51
66.62%
-0.62
20.49%
return on equity
-0.43
-
-0.42
2.10%
-0.61
43.55%
-0.92
50.92%
-0.92
0.32%
-1.62
76.55%
-0.52
67.88%
-0.87
67.91%
total debt to capitalization
0.30
-

All numbers in USD (except ratios and percentages)